craft-sa-dev Home  

PMC:1253828 / 14555-14736 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4307 0-181 sentence denotes The cells were then pre-incubated for 24 h in medium containing 0, 5, 10, 25 or 50 µM l-buthionine-[S,R]-sulfoximine (BSO) (Sigma), a drug that inhibits glutathione synthesis (31).
T4308 1-4 DT denotes The
T4309 5-10 NNS denotes cells
T4311 11-15 VBD denotes were
T4312 16-20 RB denotes then
T4310 21-34 VBN denotes pre-incubated
T4313 35-38 IN denotes for
T4314 39-41 CD denotes 24
T4315 42-43 NN denotes h
T4316 44-46 IN denotes in
T4317 47-53 NN denotes medium
T4318 54-64 VBG denotes containing
T4319 65-66 CD denotes 0
T4321 66-68 , denotes ,
T4322 68-69 CD denotes 5
T4323 69-71 , denotes ,
T4324 71-73 CD denotes 10
T4325 73-75 , denotes ,
T4326 75-77 CD denotes 25
T4327 78-80 CC denotes or
T4328 81-83 CD denotes 50
T4320 84-86 NN denotes µM
T4329 87-88 NN denotes l
T4331 88-89 HYPH denotes -
T4332 89-99 NN denotes buthionine
T4333 99-100 HYPH denotes -
T4334 100-101 -LRB- denotes [
T4335 101-102 NN denotes S
T4336 102-103 , denotes ,
T4337 103-104 NN denotes R
T4338 104-105 -RRB- denotes ]
T4339 105-106 HYPH denotes -
T4330 106-117 NN denotes sulfoximine
T4340 118-119 -LRB- denotes (
T4341 119-122 NN denotes BSO
T4342 122-123 -RRB- denotes )
T4343 124-125 -LRB- denotes (
T4344 125-130 NNP denotes Sigma
T4345 130-131 -RRB- denotes )
T4346 131-133 , denotes ,
T4347 133-134 DT denotes a
T4348 135-139 NN denotes drug
T4349 140-144 WDT denotes that
T4350 145-153 VBZ denotes inhibits
T4351 154-165 NN denotes glutathione
T4352 166-175 NN denotes synthesis
T4353 176-177 -LRB- denotes (
T4354 177-179 CD denotes 31
T4355 179-180 -RRB- denotes )
T4356 180-181 . denotes .
R2820 T4308 T4309 det The,cells
R2821 T4309 T4310 nsubjpass cells,pre-incubated
R2822 T4311 T4310 auxpass were,pre-incubated
R2823 T4312 T4310 advmod then,pre-incubated
R2824 T4313 T4310 prep for,pre-incubated
R2825 T4314 T4315 nummod 24,h
R2826 T4315 T4313 pobj h,for
R2827 T4316 T4310 prep in,pre-incubated
R2828 T4317 T4316 pobj medium,in
R2829 T4318 T4317 acl containing,medium
R2830 T4319 T4320 nummod 0,µM
R2831 T4320 T4318 dobj µM,containing
R2832 T4321 T4319 punct ", ",0
R2833 T4322 T4319 conj 5,0
R2834 T4323 T4322 punct ", ",5
R2835 T4324 T4322 conj 10,5
R2836 T4325 T4324 punct ", ",10
R2837 T4326 T4324 conj 25,10
R2838 T4327 T4326 cc or,25
R2839 T4328 T4326 conj 50,25
R2840 T4329 T4330 nmod l,sulfoximine
R2841 T4330 T4320 appos sulfoximine,µM
R2842 T4331 T4330 punct -,sulfoximine
R2843 T4332 T4330 nmod buthionine,sulfoximine
R2844 T4333 T4330 punct -,sulfoximine
R2845 T4334 T4330 punct [,sulfoximine
R2846 T4335 T4330 nmod S,sulfoximine
R2847 T4336 T4330 punct ",",sulfoximine
R2848 T4337 T4330 nmod R,sulfoximine
R2849 T4338 T4330 punct ],sulfoximine
R2850 T4339 T4330 punct -,sulfoximine
R2851 T4340 T4330 punct (,sulfoximine
R2852 T4341 T4330 appos BSO,sulfoximine
R2853 T4342 T4320 punct ),µM
R2854 T4343 T4344 punct (,Sigma
R2855 T4344 T4320 parataxis Sigma,µM
R2856 T4345 T4344 punct ),Sigma
R2857 T4346 T4320 punct ", ",µM
R2858 T4347 T4348 det a,drug
R2859 T4348 T4320 appos drug,µM
R2860 T4349 T4350 dep that,inhibits
R2861 T4350 T4348 relcl inhibits,drug
R2862 T4351 T4352 compound glutathione,synthesis
R2863 T4352 T4350 dobj synthesis,inhibits
R2864 T4353 T4354 punct (,31
R2865 T4354 T4350 parataxis 31,inhibits
R2866 T4355 T4354 punct ),31
R2867 T4356 T4310 punct .,pre-incubated